METHOD OF TREATING PATIENTS WITH STABLE EXERTIONAL ANGINA Russian patent published in 2010 - IPC A61N5/67 

FIELD: medicine.

SUBSTANCE: blood is exposed to intravenous laser irradiation of wave length 0.63 mcm, light guide end radiation power 1.5-2.0 mWt, exposure length 15-20 minutes. It is combined with drug therapy and intravenous laser irradiation of blood prescribed differentially considering duration of the disease, the level of lipid profiles, namely total cholesterol (TCH), low density lipoprotein cholesterol (LDL CH), high density lipoprotein cholesterol (HDL CH), triglycerides (TG), homocysteine (HC) level, degree of manifestation of endothelial dysfunction (nitrates/nitrites), disturbed thrombocyte and erythrocyte aggregation. If duration of the disease is less than 5 years, the TCH level is less than 4.67±0.17 mmol/l, the LDL CH is less than 2.94±0.23 mmol/l, the HDL CH is more than 1.2±0.04 mmol/l, the TG is less than 1.62±0.16 mmol/l, the HC level is less than 9.36±1.14, the nitrates/nitrites level is 35.2±2.7 mcmol/l and more, the degree of thrombocyte aggregation 27.88±0.96- 60.98±0.86%, the degree of erythrocyte aggregation 28.52±2.2 - 46.3±2.4%, 5-6 daily procedures of intravenous laser irradiation of blood are required. If duration of the disease is more than 5 years, the TCH level is more than 4.67±0.17 mmol/l, the LDL CH is more than 2.94±0.23 mmol/l, the HDL CH is less than 1.04±0.06 mmol/l, the TG is more than 1.47±0.12 mmol/l, the HC level is more than 9.36±1.14, the nitrates/nitrites level is less than 35.2±2.7 mkmol/l, the degree of thrombocyte aggregation is more than 60.98±0.86%, the degree of erythrocyte aggregation more than 46.3±2.4%, 7-8 daily procedures of intravenous laser irradiation of blood are carried out.

EFFECT: method allows improving clinical effectiveness ensured by consideration of the most important pathogenetic links of development of a chronic cardiac disease when specifying the parametres of laser therapy.

5 tbl, 2 ex